TAS-114

· Taiho Oncology, Inc.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for TAS-114, covering 2017-08-04 to 2024-09-05. Get the full timeline:

Most recent: Clinical Trial Update: A Safety, Tolerability and Pharmacokinetic Study of TAS-114 in Combination With Capecitabine in Patients With Advanced Solid Tumors [Phase 1]

See pricing